Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate Change

4th Mar 2008 07:00

Ultrasis PLC04 March 2008 Ultrasis plc ("Ultrasis" or the "Company") Appointment of non-executive Director Further to the Annual General Meeting of the Company on 26 February 2008 inwhich the intention to appoint Anthony Knight as non-executive Director wasannounced, Ultrasis is pleased to advise that the appointment becomes effectivefrom 4 March 2008. For further information please contact: Ultrasis PlcNigel Brabbins, Chief Executive Officer 020 7566 3900 [email protected] Nomad and Joint Broker - JMFinn Capital Markets (now trading as FinnCap)Geoff Nash 020 7600 1658 Appendix Anthony has over 30 years of experience of the pharmaceutical industry and hehas held senior positions in marketing, sales, commercial management, training,business development, business information, general management and as anon-executive director of both private companies and a plc. Most recently,Anthony was the Non-Executive Chairman of Meldex International plc (formerlyBioProgress plc). Prior to that he served on the board of Parke-Davis UK wherehe was the Customer Marketing Director, until the merger with Pfizer when he wasa senior member in the UK integration team. Anthony left to establish thePortland Partnership with its primary focus of consulting on Business Strategyin the Healthcare Sector advising on strategy, challenging existing businessmodels and developing alternative solutions. Anthony is a Fellow of the RoyalSociety of Arts. In accordance with Schedule 2(g) of the AIM Rules, the following information inrelation to the appointment of Anthony Knight to the Board of Ultrasis isdisclosed: Full name: Anthony John KnightAge: 57 Anthony Knight holds and has held within the five preceding years the following directorships and partnerships: Current directorships and partnerships:Stanbridge Earls School Trust - Director and TrusteeStanbridge Earls Trading Ltd - Director Past directorships and partnerships:BioProgress plc/Meldex International - Non-executive DirectorPortland Partnership - Founding PartnerMediary Ltd - Non-executive DirectorRoyal Southampton Yacht Club - DirectorAmpfield School Governors - ChairmanAmpfied Parish Council - Vice Chairman Save as set out above, there is no further information to be disclosed in respect of Schedule 2(g) of the AIM Rules. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Ultrasis Plc
FTSE 100 Latest
Value8,275.66
Change0.00